Microchip Technology vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 44)

Microchip Technology

ChallengerSemiconductors

Microcontrollers

Embedded microcontroller leader (PIC, AVR, ARM MCUs) with $7.6B FY2024 revenue; deep inventory correction 2024-2025 after 46% revenue decline from peak; Atmel ($3.56B) and Microsemi ($8.35B) acquisitions.

AI VisibilityBeta
Overall Score
C44
Category Rank
#1 of 1
AI Consensus
87%
Trend
stable
Per Platform
ChatGPT
40
Perplexity
35
Gemini
37

About

Microchip Technology is a leading provider of microcontroller, digital signal controller, and analog semiconductor solutions for embedded control applications, founded in 1989 when Steve Sanghi led a management buyout of General Instrument's Microelectronics Division in Chandler, Arizona, where the company remains headquartered and trades on Nasdaq (MCHP). The company generated approximately $7.6 billion in net sales for fiscal year 2024 (ending March 31, 2024) under CEO Ganesh Moorthy, who succeeded Sanghi (who remains Executive Chair) in 2021. Microchip Technology has built one of the broadest microcontroller portfolios in the semiconductor industry through strategic acquisitions: the 2016 acquisition of Atmel ($3.56B) added AVR and SAM ARM-based microcontrollers, and the 2018 acquisition of Microsemi ($8.35B) added FPGAs, application-specific integrated circuits, timing products, and defense/aerospace-grade semiconductors that expanded Microchip's total addressable market substantially.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

44
Overall Score
90
#1
Category Rank
#9
87
AI Consensus
60
stable
Trend
stable
40
ChatGPT
99
35
Perplexity
99
37
Gemini
83
39
Claude
96
40
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.